Pink Printed Dress
Published: Oct 10, 2018 Pages: 105
SKU-Code: EKS-20-2017 Region: Global

Buy Now
$3499
Get Free 10% Customization

License Type

Add to Cart

Download Brochure

Gene therapy is an experimental technique that encompasses the replacement of mutated genes with healthy genes. Gene therapy is considered to be an effective treatment for chronic diseases as they cause minimum side effects with maximum efficacy and may help in an eradication of disease at a root cause level.

Its an experimental technique that uses genes from another source to treat or prevent any type of genetic disorder. The rise in prevalence of cancer, benefits of cancer gene therapy over conventional cancer therapies, rising awareness among developing nations, approval of gene therapy products in developed nations like Europe and the advancement in this field are the major factors that are driving the market growth.

The growing popularity of the gene therapy market can be correlated with increasing number of clinical trials due to rising incidence of various types of skin disease, rise in funding for R&D activities, increase in awareness, and investment from government bodies. Over the years ethical acceptance of gene therapy especially with respect to the cancer treatment has grown which is further fueling the growth of gene therapy market. Moreover, rise in biotechnological funding, initiatives taken by government bodies to encourage R&D activities are also other factors driving the gene therapy market. However high costs associated with the treatment, unwanted immune response, pitfall in current technologies, stringent laws and safety and challenges in commercialization of gene therapy market are restraining the market growth.

The overall global gene therapy market is expected to witness a significant growth as it may reach approximately US$2543 million by the end of the year 2026. Several bioengineers, professionals are focusing to develop and support gene therapies with improved efficacy and safety and are aiming more towards advanced platforms for the engineering of vectors. It has also led to discovery of many novel molecular targets which has further enhanced and strengthened the research and product pipeline. Hence, the diverse product pipeline is driving factor for the growth of gene therapy market. The overall gene therapy market is segmented based on therapy area where cancer is dominating the market. Based on geographic area US is holding the major market share among Europe, Asia, Australasia.

The various key players that are playing the lead role in the gene therapy market are Pfizer, Celegene, Spark Therapeutics, GlaxoSmithKline, Blubirdbio Therapeutics, Sanofi, Uniqure, Orchard Therapeutics, Abeona Therapeutics, OxfordBiomedica. Glybera, the first gene therapy product which is used for the treatment of lipoprotein lipase deficiency is the product of Uniqure and has been given an orphan drug status in the European Union as well as the US. Strimvelis, another gene therapy product developed by GlaxoSmithKline which proved to be successful against ADA-SCID (Severe Combined Immune Deficiency). SPK9001 is an another breakthrough product against Hemophilia B was developed by Spark and Pfizer, which involves a bioengineered gene designed to prompt the body to produce increased levels of a different clotting factors.

The report provides an extensive study on the current market landscape of gene therapies by therapy area, by regions, by vectors and by key players, featuring an elaborate discussion on the future potential of this evolving market.

Key questions answered

  • Global Gene Therapy Market by Value; 2014-2026
  • Global Gene Therapy Market Share by Therapy Area; 2015
  • Global Gene Therapy Market Share by Vectors; 2015
  • Global Gene Therapy Clinical Trials by Therapy Areas; 2017
  • Global Gene Therapy Market Share by Regions; 2018
  • Global Gene Therapy Market by M&A Deals; 2017
  • US Gene Therapy Market by Value; 2013-2026
  • US Gene Therapy Share by Therapy Area; 2013-2026
  • US Hematology Gene Therapy Market by Value; 2013-2026
  • US Oncology Gene Therapy Market by Value; 2013-2026
  • US Infectious disease Gene Therapy Market by Value; 2013-2026
  • US Muscular Disease Gene Therapy Market by Value; 2013-2026
  • Europe Gene Therapy Market by Value; 2014-2026
  • Europe Gene Therapy Market Share by Sector; 2014-2026
  • Europe Gene Therapy Market by Companies; 2014-2026
  • Europe Gene Therapy Market by Academic and Government Research Institutions; 2014-2026
  • Europe Gene Therapy Market by Contract and Research Institutions; 2014-2026
  • Asia Gene Therapy Market by Value; 2014-2026
  • Australasia Gene Therapy Market by Value; 2014-2026
  • Number of Approved Gene Therapy Trials Worldwide; 1989-2015
  • Patent Landscape
  • Growth drivers, future opportunities and challenges in the market
  • Merger and Acquisition, and Collaboration of Key Players
  • Detailed company profiling of key market players


Related Reports